Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
NASHVILLE, Tenn. -- Racial biases persist in the use of pulse oximetry devices for patients with acute hypoxemic respiratory failure (AHRF) requiring very high levels of oxygen support, a ...
Mumbai - 234-2 (30 ov), Sarfaraz Khan 6(3) Musheer Khan 26(25), need 3 runs Mumbai - 142-1 (20 ov), Rohit Sharma 98(60) Musheer Khan 1(2), need 95 runs Mumbai - 71-0 (10 ov), Rohit Sharma 54(29) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback